Search

Positive results from a clinical trial published in The New England Journal of Medicine show that the combination of the immunotherapy drugs ipilimumab (Yervoy™) and nivolumab (Opdivo™), produced significantly better outcomes than ipilimumab alone in patients with advanced melanoma. A second piece in the same issue from MSK details a dramatic response occurring after a single dose of the combination therapy.

… Monday, April 20, 2015 Researchers from Memorial Sloan Kettering Cancer Center (MSK) are reporting exciting results in the field of cancer immunology. Positive results from a clinical trial published today in The New England Journal of Medicine show that the combination of the immunotherapy drugs ipilimumab

Diane Reidy-Lagunes sits down with Mary Elizabeth Williams to discuss what it was like being part of a phase 1 clinical trial, how clear communication can affect health outcomes, how guilt often accompanies survival, and what not to say to a cancer patient.

… Monday, November 29, 2021 When Mary Elizabeth Williams was diagnosed with stage 4 melanoma, she says: “My identity and my relationship with my mortality changed. That was the beginning of my new life.” Her decision to publicly disclose her diagnosis soon after receiving it was easy, she says. “I went

Data from 25,000 patients is helping scientists answer this and many other important questions.

… Thursday, February 3, 2022 Several years ago, in a lab meeting, one of Nikolaus Schultz’s postdoctoral fellows posed a question: “Do you think it’s possible to predict, based on the genomic profile of an individual tumor, which organs it might metastasize to?” And just like that, a research project was

Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce that Selwyn M. Vickers, MD, FACS, President and Chief Executive Officer of MSK, and Andrea Schietinger, PhD, Associate Member of the Immunology Program at the Sloan Kettering Institute will be honored at the 2023 American Association for Cancer Research (AACR) Annual Meeting for their significant contributions to cancer research and care.

… Friday, April 14, 2023 Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce that Selwyn M. Vickers, MD, FACS , President and Chief Executive Officer of MSK, and Andrea Schietinger, PhD , Associate Member of the Immunology Program at the Sloan Kettering Institute will be honored at the

Learn how blood tests called liquid biopsies may be used to find, diagnose, and treat cancer anywhere in the body.

… Monday, September 15, 2025 A blood test to find cancer even before it shows any symptoms is the dream of cancer doctors everywhere.   Researchers at Memorial Sloan Kettering Cancer Center (MSK) are among those hard at work on developing a test that can accurately pick up signs of a tumor anywhere in

Memorial Sloan Kettering President and CEO Craig Thompson reflects on the life and career of cancer research pioneer Janet Rowley.

… Friday, December 20, 2013 Summary Memorial Sloan Kettering President and CEO Craig Thompson reflects on the life and career of cancer research pioneer Janet Rowley. I learned with great sadness earlier this week of the death of Janet Davison Rowley. A few years ago, the New York Times called Dr. Rowley

Today is the fourth anniversary of same-sex marriage being legalized in the United States. Today also marks the start of WorldPride, which celebrates the progress made toward LGBTQ+ equality while underscoring changes still needed.

… Thursday, June 27, 2019 This week is the fourth anniversary of same-sex marriage being legalized in the United States. It also marks the start of WorldPride , which celebrates the progress made toward LGBTQ+ equality while underscoring changes still needed. June is also National Cancer Survivor Month

Learn the differences between physician assistants and nurse practitioners and the important roles they play at Memorial Sloan Kettering.

… Monday, July 6, 2020 At Memorial Sloan Kettering, teamwork is the name of the game. It’s not just one professional taking care of a patient; care teams ensure that every person who walks through the doors is provided for and supported. Vital members of a patient’s care team include physician assistants

An international, multi-center study has revealed the discovery of a novel oncogene that is associated with uveal melanoma, the most common form of eye cancer. Researchers have isolated an oncogene called GNA11 and have found that it is present in more than 40 percent of tumor samples taken from patients with uveal melanoma.

… Wednesday, November 17, 2010 An international, multi-center study has revealed the discovery of a novel oncogene that is associated with uveal melanoma , the most common form of eye cancer. Researchers have isolated an oncogene called GNA11 and have found that it is present in more than 40 percent of

Learn more about entrectinib, a targeted therapy being evaluated in patients with solid tumors.

… Wednesday, April 5, 2017 Summary Entrectinib is a targeted therapy that passed safety and tolerability standards in patients with solid tumors in two phase I trials. Now, the drug will be tested in a phase II trial. At last year’s annual meeting of the American Association for Cancer Research (AACR),